Cargando…
A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology
Hepatocellular carcinoma (HCC) is a serious global health problem, and hepatitis B virus (HBV) infection remains the leading cause of HCC. It is standard care to administer antiviral treatment for HBV-related HCC patients with concurrent anti-cancer therapy. However, a drug with repressive effects o...
Autores principales: | Yin, Xiaofeng, Li, Jinchuan, Hao, Zheng, Ding, Rui, Qiao, Yanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420877/ https://www.ncbi.nlm.nih.gov/pubmed/36046748 http://dx.doi.org/10.3389/fcimb.2022.964469 |
Ejemplares similares
-
A Traditional Chinese Medicine, Maoto, Suppresses Hepatitis B Virus Production
por: Rahman, Md. Arifur, et al.
Publicado: (2021) -
Traditional Chinese Medicine Tanreqing Targets Both Cell Division and Virulence in Staphylococcus aureus
por: Yang, Weifeng, et al.
Publicado: (2022) -
ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas
por: Li, Jinchuan, et al.
Publicado: (2022) -
Mechanisms by Which Traditional Chinese Medicines Influence the Intestinal Flora and Intestinal Barrier
por: Che, Qingya, et al.
Publicado: (2022) -
A new approach to overcoming antibiotic-resistant bacteria: Traditional Chinese medicine therapy based on the gut microbiota
por: Xue, Peng, et al.
Publicado: (2023)